Oragenics Inc (OGEN) Stock Price & Analysis
Oragenics Inc (OGEN) rose 2.31% to USD 0.51 as of September 8, 2026 at 08:19 UTC, according to Nexqual real-time market data.
OGEN last closed at USD 0.51; the session ranged USD 0.5–0.52 on volume of 8,312 shares. Market capitalization is —, with a 52-week range of USD 0.48–1.45 (ASE). Source: Nexqual, September 8, 2026 at 08:19 UTC.
Key Statistics (as of September 8, 2026 at 08:19 UTC)
| Price | USD 0.51 |
|---|---|
| Change | ▲ 2.31% (up) |
| Previous Close | USD 0.51 |
| Open | USD 0.51 |
| Day Range | USD 0.5 – 0.52 |
| 52-Week Range | USD 0.48 – 1.45 |
| Volume | 8,312 shares |
| Market Cap | — |
| Exchange | ASE |
Technical Analysis (OGEN)
Nexqual's technical model rates OGEN "STRONG SELL" based on 0 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 08:19 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 43.2 (neutral) |
| vs SMA50 | Below (USD 0.54) |
| MACD | -0.01 (negative) |
From Oragenics Inc's Latest SEC 10-K Filing (filed 2026-03-16)
Key Strengths & Strategy (as disclosed to the SEC)
- The first developer to receive FDA marketing approval for an orphan drug is entitled to a seven-year exclusive marketing period in the U.S. for the orphan drug indication.
- Interim patent extensions are not available for a drug for which an NDA has not been submitted.   Section 505(b)(2) New Drug Applications   Most drug products obtain FDA marketing approval pursuant to an NDA or an ANDA.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| JAGX | Jaguar Health, Inc. | USD 0.6 | ▼ 18.25% |
| TNXP | Tonix Pharmaceuticals Holding C | USD 13.14 | ▼ 1.79% |
| VTVT | vTv Therapeutics Inc. | USD 33.35 | ▼ 0.15% |
| IGC | IGC Pharma, Inc. | USD 0.3 | ▼ 0.67% |
| IBIO | iBio, Inc. | USD 1.31 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 08:19 UTC. This page is informational and not investment advice.